Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV:
LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech
company that leverages advancements in science and technology to
build breakthrough ventures that transform human wellness, is
pleased to report that its U.S. biosciences subsidiary Mikra
Cellular Sciences Inc. (“Mikra”) has received the first shipment of
Serenity, a natural supplement for supporting
symptoms of anxiety, at its warehouse in California in time for
sale on Black Friday, November 24. To order
Serenity starting this Friday
,
customers should visit wearemikra.com and are encouraged to sign up
for updates and promotional offers at
https://bit.ly/serenity-sign-up.
In addition, Mikra wishes to bring attention to
the recent article in The New York Times, After
Antidepressants, a Loss of Sexuality1, documenting modern
medicine's evolving understanding of the potential side effects of
selective serotonin reuptake inhibitors (SSRIs), the typical
frontline treatment prescribed for patients suffering from
anxiety:
"Doctors and patients have long known that
antidepressants can cause sexual problems... Well over half of
people taking the drugs report such side effects. Now, a small but
vocal group of patients is speaking out about severe sexual
problems that have endured even long after they stopped taking
selective serotonin reuptake inhibitors... The drugs’ effects have
been devastating, they said, leaving them unable to enjoy sex or
sustain romantic relationships."
"With so many young people grappling with
symptoms of anxiety in our modern world, we felt there was an
opportunity to introduce a natural, science driven alternative to
those seeking relief," explained Meni Morim, CEO of Lifeist. "Our
in-depth analysis of the extensive clinical research on
steam-extracted lavender oil2 compelled us to move forward to
develop a natural supplement for anxiety relief and introduce
Serenity to the market. In particular, we found
the lack of habit-forming abuse potential very encouraging.”3
What sets Serenity apart from
competing products is the consistent GCMS-verified dose4 of the
active ingredient combined with the integration of Mikra's
proprietary polyterpene blend that provides an agreeable flavor and
aftertaste, addressing a common complaint voiced by early adopters
of competing lavender oil products of a "perfume-like" taste. With
Lifeist's expertise with fragrant and flavorful botanicals,
Serenity is poised to become the best tasting
lavender oil extract supplement on the market. Plus,
Serenity ships with a full 30-day supply in every
bottle, as compared to the typical 7- or 14-day supply sold in
competing lavender-based products.
Mikra is pushing biosciences beyond the expected
with the belief that it is possible to add more active, vigorous,
enjoyable and valuable years to your life through protecting and
maintaining your cellular health.
Lifeist is committed to bringing natural
products backed by real science to current and future customers and
looks forward to introducing new products in the first half of
2024.
About Lifeist Wellness
Inc.Sitting at the forefront of the post-pandemic wellness
revolution, Lifeist leverages advancements in science and
technology to build breakthrough companies that transform human
wellness. Portfolio business units include: CannMart, which
operates a B2B wholesale distribution business facilitating
recreational cannabis sales to Canadian provincial government
control boards including for CannMart Labs, a BHO extraction
facility producing high margin cannabis 2.0 products; Australian
Vapes, one of Australia’s largest online retailers of vaporizers
and accessories; and Mikra, a biosciences and consumer wellness
company developing and selling innovative therapies for cellular
health. Information on Lifeist and its businesses can be
accessed through the links
below:www.lifeist.comhttps://cannmart.comhttps://wearemikra.comwww.australianvaporizers.com.au
Contact:Meni MorimCEOLifeist
Wellness Inc.Ph: 647-362-0390Email: ir@lifeist.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release or has in any way approved
or disapproved of the contents of this press release.
Forward Looking InformationThis
news release contains “forward-looking information” within the
meaning of applicable securities laws. All statements contained
herein that are not historical in nature contain forward-looking
information. Forward-looking information can be identified by words
or phrases such as “may”, “expect”, “likely”, “should”, “would”,
“plan”, “anticipate”, “intend”, “potential”, “proposed”,
“estimate”, “believe” or the negative of these terms, or other
similar words, expressions and grammatical variations thereof, or
statements that certain events or conditions “may” or “will”
happen.
The forward-looking information contained
herein, including, without limitation, statements related to the
expected date that Serenity will be available for sale and the
anticipated benefits of using Serenity instead of antidepressants
to treat anxiety are made as of the date of this news release and
are based on assumptions management believed to be reasonable at
the time such statements were made, including without limitation,
that Mikra will be able to take orders for
Serenity on Black Friday expectations relating to
the effectiveness of lavender oil and its extracts in treating
anxiety as demonstrated in published materials and studies, its
expectation that the nutraceutical market will develop as currently
anticipated, the nutraceutical market will continue to be a
multi-billion dollar high-margin market, expectations that Serenity
will gain market acceptance as a natural supplement alternative for
the treatment of anxiety, along with the expansion of the market
for nutraceutical products, as well as other considerations that
are believed to be appropriate in the circumstances. While we
consider these assumptions to be reasonable based on information
currently available to management, there is no assurance that such
expectations will prove to be correct. By its nature,
forward-looking information is subject to inherent risks and
uncertainties that may be general or specific and which give rise
to the possibility that expectations, forecasts, predictions,
projections or conclusions will not prove to be accurate, that
assumptions may not be correct, and that objectives, strategic
goals and priorities will not be achieved. A variety of factors,
including known and unknown risks, many of which are beyond our
control, could cause actual results to differ materially from the
forward-looking information in this news release. Such factors
include, without limitation: the failure to successfully make
Serenity available for sale as anticipated and in a timely manner,
the failure of Serenity, a natural supplement alternative, to
demonstrate a notable effectiveness in treating general anxiety
disorder or other anticipated health benefits, the inability of the
Company to develop Mikra’s business as anticipated, unanticipated
changes to current regulations that would adversely impact Mikra’s
business, unforeseen developments that would delay Mikra’s ability
to sell Serenity, the risk that the expected demand for
nutraceutical products in general and those of Mikra in particular
does not develop as anticipated and risks relating to the Company’s
ability to execute its business strategy and the benefits
realizable therefrom. Additional risk factors can also be found in
the Company’s current MD&A filed under the Company’s SEDAR
profile at www.sedarplus.ca. Readers are cautioned not to put
undue reliance on forward-looking information. The Company
undertakes no obligation to update or revise any forward-looking
information, whether as a result of new information, future events
or otherwise, except as required by applicable law. Forward-looking
statements contained in this news release are expressly qualified
by this cautionary statement.
Source: Lifeist Wellness Inc.
1 After Antidepressants, a Loss of Sexuality
https://www.nytimes.com/2023/11/09/health/antidepressants-ssri-sexual-dysfunction.html2
Efficacy and safety of lavender essential oil capsules among
patients suffering from anxiety disorders: A network meta-analysis
https://www.nature.com/articles/s41598-019-54529-93 No Abuse
Potential of Lavender Oil Extract
https://academic.oup.com/ijnp/article/24/3/171/60293714
GCMS-verified doses have been rigorously confirmed through Gas
Chromatography-Mass Spectrometry analysis, and provide a high level
of confidence in the accuracy and reliability of the specified
dosage, making it a crucial aspect of quality control in industries
where precise and consistent dosing is essential for safety and
efficacy.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/9db007ac-4834-4374-9476-c5f05724590c
Lifeist Wellness (TSXV:LFST)
過去 株価チャート
から 4 2024 まで 5 2024
Lifeist Wellness (TSXV:LFST)
過去 株価チャート
から 5 2023 まで 5 2024